drugset / Trial / NCT00276029
TNF Alpha in Refractory Asthma
RandomizedCrossoverDouble-blindTreatment
Summary
The purpose of this study was to investigate whether the administration of etanercept to patients with severe asthma improved their asthma related quality of life and a measure of the degree of reactivity of the airways
Timeline
- Start
- 2003-12
- Primary completion
- —
- Completion
- 2004-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Etanercept | Protein / enzyme biologic | 25 mg | — |